Correlation Between Micron Technology and BioMark Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Micron Technology and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Micron Technology and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Micron Technology and BioMark Diagnostics, you can compare the effects of market volatilities on Micron Technology and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Micron Technology with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Micron Technology and BioMark Diagnostics.

Diversification Opportunities for Micron Technology and BioMark Diagnostics

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Micron and BioMark is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Micron Technology and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Micron Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Micron Technology are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Micron Technology i.e., Micron Technology and BioMark Diagnostics go up and down completely randomly.

Pair Corralation between Micron Technology and BioMark Diagnostics

Allowing for the 90-day total investment horizon Micron Technology is expected to generate 0.48 times more return on investment than BioMark Diagnostics. However, Micron Technology is 2.07 times less risky than BioMark Diagnostics. It trades about 0.04 of its potential returns per unit of risk. BioMark Diagnostics is currently generating about 0.01 per unit of risk. If you would invest  8,182  in Micron Technology on September 14, 2024 and sell it today you would earn a total of  1,935  from holding Micron Technology or generate 23.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Micron Technology  vs.  BioMark Diagnostics

 Performance 
       Timeline  
Micron Technology 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Micron Technology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Micron Technology unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Micron Technology and BioMark Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Micron Technology and BioMark Diagnostics

The main advantage of trading using opposite Micron Technology and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Micron Technology position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.
The idea behind Micron Technology and BioMark Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals